Fig. 4From: The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiationFive-year survival curves (eliminate patients with lymph node metastases). A 5-year PFS of all patients in different subgroups (p = 0.155). B 3-year OS of all patients in different subgroups (p = 0.461). OS, overall survival; PFS, progression free survivalBack to article page